Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Boulware

Showing results (11-20 of 409) with videos related to

Pageof 41
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2019
Cryptococcal Antigen Screening and Preemptive Treatment-How Can We Improve Survival?Radha Rajasingham, David R Boulware
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19David R Boulware, Mahsa Abassi
Lancet (London, England)|March 14, 2015
HIV care: ART adherence support and cryptococcal screeningRadha Rajasingham, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2016
Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness AnalysisMatthew Merry, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2019
New US Food and Drug Administration Approvals Decrease Generic Flucytosine CostsRadha Rajasingham, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2012
Reconsidering cryptococcal antigen screening in the U.S. among persons with CD4 <100 cells/mcLRadha Rajasingham, David R Boulware
Annals of Internal Medicine|November 28, 2022
Ongoing Need for Clinical Trials and Contemporary End Points for Outpatient COVID-19Todd C Lee, David R Boulware
Revista Do Instituto De Medicina Tropical De Sao Paulo|October 15, 2015
LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITYJose E Vidal, David R Boulware
Minnesota Medicine|December 26, 2008
The trials of the returning traveler: ciprofloxacin failure in enteric feverAlison M Bormann, David R Boulware
Annals of Internal Medicine|March 15, 2021
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19Caleb P Skipper, David R Boulware
Pageof 41

Showing results (11-20 of 409) with videos related to

Sort By:
Pageof 41
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2019
Cryptococcal Antigen Screening and Preemptive Treatment-How Can We Improve Survival?Radha Rajasingham, David R Boulware
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19David R Boulware, Mahsa Abassi
Lancet (London, England)|March 14, 2015
HIV care: ART adherence support and cryptococcal screeningRadha Rajasingham, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2016
Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness AnalysisMatthew Merry, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2019
New US Food and Drug Administration Approvals Decrease Generic Flucytosine CostsRadha Rajasingham, David R Boulware
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2012
Reconsidering cryptococcal antigen screening in the U.S. among persons with CD4 <100 cells/mcLRadha Rajasingham, David R Boulware
Annals of Internal Medicine|November 28, 2022
Ongoing Need for Clinical Trials and Contemporary End Points for Outpatient COVID-19Todd C Lee, David R Boulware
Revista Do Instituto De Medicina Tropical De Sao Paulo|October 15, 2015
LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITYJose E Vidal, David R Boulware
Minnesota Medicine|December 26, 2008
The trials of the returning traveler: ciprofloxacin failure in enteric feverAlison M Bormann, David R Boulware
Annals of Internal Medicine|March 15, 2021
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19Caleb P Skipper, David R Boulware
Pageof 41